Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2555A North Pavilion, 1802 6th Ave S
Birmingham, AL 35294Phone+1 205-934-9591
Education & Training
All India Institute of Medical SciencesClass of 1984
Certifications & Licensure
CA State Medical License 1996 - 2026
AL State Medical License 2014 - 2025
MN State Medical License 1994 - 1997
Publications & Presentations
PubMed
- Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.Kendall Diebold, Garrett Bourne, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia & Lymphoma. 2024-11-01 - CRISPR screen of venetoclax response-associated genes identifies transcription factor ZNF740 as a key functional regulator.Lixia Zhang, Xinyue Zhou, Sajesan Aryal, Virginia Veasey, Pengcheng Zhang
Cell Death & Disease. 2024-08-27 - 1 citationsLow-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies.Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Zaid Al-Kadhimi
Ejhaem. 2024-06-01
Press Mentions
Accelerated Approval of New Frontline TKI Use in CML Raises QuestionsDecember 2nd, 2024
Impact of Access to Care on 1-Year Mortality Following Allogeneic Blood or Marrow TransplantationJanuary 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
